News

CNS Issue Brief: The Dual-Use Dilemma

About the image

Michael Tu

Research Associate, The James Martin Center for Nonproliferation Studies

H5N1's high mortality rate and the possibility that it might mutate to become easily transmissible from human-to-human make it a high priority research topic for public health preparedness and pandemic prevention efforts. However, these same factors mean research involving the virus poses public health and biosecurity risks, evoking a debate about the dual-use nature of this research.

Recently, researchers in the Netherlands and the United States identified genetic mutations that could also enable H5N1 to become easily transmissible from one human to another. In the United States and abroad, controversy has emerged about whether the details of these two particularly sensitive H5N1 studies should be openly published to aid global pandemic preparedness or withheld in the interests of national security.

Michael Tu explores the uncertainties around H5N1, federal strategies for managing dual-use research of concern and other issues around this unresolved controversy. The stakes are high.  As Tu notes, "The importance of finding a workable solution and continuing to gain knowledge on H5N1 cannot be overstated. By some estimates, a pandemic form of the virus could kill up to 1 billion people globally."

Read the full issue brief.

Stay Informed

Sign up for our newsletter to get the latest on nuclear and biological threats.

Sign Up

85% of Registered Voters Support the United States Working with China to Mitigate AI Risks, according to New Poll

News

85% of Registered Voters Support the United States Working with China to Mitigate AI Risks, according to New Poll

New YouGov polling commissioned by NTI and ReThink Media finds that nearly 80 percent of registered voters, across party lines, say it is in the interest of U.S. national security to work with China to mitigate catastrophic threats associated with nuclear risks, AI development, and bioterrorism.


NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations‌

News

NTI, Concordia AI Launch International Working Group to Improve Biological Capability Evaluations‌

NTI | bio and Concordia AI, with technical input from SecureBio, have launched the AIxBio Technical Working Group on Evaluation Practice. Convened through the AIxBio Global Forum, the Working Group will bring together experts from organizations in China, the European Union, the United Kingdom, and the United States that develop or conduct biological capability evaluations of AI systems.


NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur

News

NTI | bio Engages Global Leaders at GHS2026 in Kuala Lumpur

NTI | bio experts will take part in several GHS2026 sessions, including a preview of findings from the forthcoming Africa Health Security (AHS) Index and a timely discussion on strengthening health security partnerships amid declining resources.


See All News

Close

My Resources

Subscribe to NTI

Sign up for regular updates on innovative, real-world solutions to existential threats.

Get Updates